carboxyphthalato-1,2-diaminocyclohexaneplatinum

Known as: 1,2-diaminocyclohexane(4-carboxyphthalato)platinum(II), (4-carboxyphthalato)(1,2-diaminocyclohexane)-platinum(II), DACCP 
A second-generation platinum analog with potential antineoplastic activity. Dacplatinum alkylates DNA at the N-7 position of guanine, thereby… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2015
01219832015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Attention-deficit/hyperactivity disorder (ADHD) has become a major aspect of the work of child and adolescent psychiatrists and… (More)
  • table 1
  • figure 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
Review
1985
Review
1985
This review describes the current clinical results of phase I and II trials of new antitumor drugs such as the new anthracyclines… (More)
Is this relevant?
1984
1984
The antitumor activity of a new highly water-soluble platinum derivative, (1,2-diaminocyclohexane)(isocitrato)platinum(II) (NSC… (More)
Is this relevant?
1984
1984
A phase-II trial of the second-generation platinum analog 1,2-diaminocyclohexane (4-carboxyphalato) platinum (II) (DACCP) was… (More)
  • table 2
Is this relevant?
1984
1984
In an effort to investigate the antitumor activity of new cisplatin analogues, 1,2-diaminocyclohexane-(4-carboxyphthalato… (More)
Is this relevant?
Review
1983
Review
1983
Since the discovery of the antitumor activity of cis-dichlorodiammine platinum (II) in various tumor systems by B. Rosenberg in… (More)
Is this relevant?
Review
1983
Review
1983
  • Masumi Ogawa
  • Gan no rinsho. Japan journal of cancer clinics
  • 1983
4'-Epiadriamycin demonstrated considerable efficacies in lymphomas, breast cancer and soft part sarcomas with reduced… (More)
Is this relevant?